Status:
ENROLLING_BY_INVITATION
FastForward: A Prospective Analysis of Long-term Fasting and Subsequent Food Reintroduction in Humans
Lead Sponsor:
Buchinger Wilhelmi Development & Holding GmbH
Collaborating Sponsors:
ETH Zurich
Conditions:
Diabetes (DM)
Pre Diabetes
Eligibility:
All Genders
18-90 years
Brief Summary
This study explores what happens in the body and wellbeing during and after a period of long-term fasting. At the Buchinger Wilhelmi Clinic, participants follow a medically supervised fasting program ...
Detailed Description
Dear prospective study participants, For optimal results of a fasting cure, the investigators would like to better understand the phase of food reintroduction, in which food is taken back after fasti...
Eligibility Criteria
Inclusion
- Men and women
- Fasting for 5+ days at the Buchinger Wilhelmi clinic in Überlingen or Marbella
- Age: 18-90 years old
- Signed informed consent
Exclusion
- Not able to sign the informed consent
- Diagnosed with cachexia, anorexia nervosa, advanced kidney, liver or cerebrovascular insufficiency.
- Chronic manifest psychical and psychiatric diseases
- Participation in another study
- Pregnancy or breastfeeding
Key Trial Info
Start Date :
August 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT07155993
Start Date
August 1 2024
End Date
December 1 2026
Last Update
September 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Buchinger Wilhelmi Klinik
Überlingen, Baden-Wurttemberg, Germany, 88662